Lloyd’s Insurers Drop on Speculation Over Hurricane Harvey Costs
Lloyd's of London insurers dropped amid speculation that they will suffer losses from Tropical Storm Harvey that's battering Houston, the epicenter of the U.S. oil industry.
Lloyd's of London insurers dropped amid speculation that they will suffer losses from Tropical Storm Harvey that's battering Houston, the epicenter of the U.S. oil industry.
U.S. government debt prices were sharply higher on Tuesday, following news that tensions between North Korea and the West had once again intensified.
Missile launches from North Korea have become almost routine, but the one fired this morning was a little different.

The entire 12,000 member Texas National Guard deployed to deal with the destruction wreaked by Hurricane Harvey; a storm some suggest could destroy up to $20 billion in insured property largely due to heavy flooding, which would make it one of the costliest storms in U.S. history. (Photos: Texas Military Department)
...Read the rest of this story
Gold jumped to its highest since November on Tuesday as investors bought bullion as insurance against falling prices of other assets after North Korea tested a missile over Japan. "Funds and traders are filling their boots with gold at the moment and so far that's justified," said Ole Hansen, head of commodity strategy at Saxo Bank in Copenhagen. Spot gold, which rose for a third straight session, was up 0.9 percent at $1,321.04 an ounce by 0940 GMT after touching $1,325.94, its highest since Nov. 9.

Comcast Corp may be best known as a cable company, but it is banking on remote-controlled door locks and cameras as well as other "smart-home" offerings to accelerate its growing home security business. The push to diversify comes at a time when more U.S. consumers who are dropping traditional cable television packages, or cutting the cord, in favor of cheaper alternatives. Comcast and its rivals want to offer more services in the home to increase their revenues and create more loyal customers.

So-so results for a new type of cholesterol drug have left Merck in a quandary: Does the company try to bring it to market or scrap it? A large, long-term study of the drug showed that it prevents heart ...